+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Healthcare Contract Research Organizations Services Market to 2027 - Service Type; Therapeutic Indication; End User, and Country

  • ID: 5138180
  • Report
  • August 2020
  • Region: Europe
  • 86 pages
  • The Insight Partners
UP TO OFF
until Sep 30th 2021

FEATURED COMPANIES

  • ICON plc
  • IQVIA INC
  • PRA Health Sciences
  • Syneos Health
The Europe healthcare contract research organizations (CRO) services market is expected to reach US$ 26,094.15 million by 2027 from US$ 13,776.13 million in 2019. The market is estimated to grow at a CAGR of 8.5% during 2020–2027. The growth of the healthcare contract research organizations (CRO) services market is primarily attributed to the growing number of clinical trials and increasing expenditure in R&D and outsourcing activities in the European region. Factors such as stringent regulations for approval of drugs hamper the growth of the market. Additionally, rising biosimilars and biologics market and advancement of technology in research field are likely to fuel the growth of the healthcare contract research organizations (CRO) services market during the forecast period.

Contract research organization (CRO) provides support services to the pharmaceutical, biotechnology, and medical device companies throughout the development of the product. Pharmaceutical & biotechnology companies and the medical device industry require various testing services such as preclinical services, clinical research services, analytical testing services, bio analytical testing services, and regulatory services. CROs are specifically designed to perform these testing services to reduce the in-house cost and time of the companies, required to conduct the extensive range of testing services to comply with the national and international regulatory standards.

Clinical trials play a determinant role in drug approvals and its efficacy over diseases. The studies help in understanding best medical approaches in certain therapeutic areas. The healthcare systems are observing rapid increase in the number of clinical trials. Factors such as growing demand for novel drugs and medical equipment, increasing prevalence of chronic conditions, and growth in funding programs to conduct clinical trials are responsible to increase the number of clinical trials.

The management of these clinical trials requires extended research facilities, dedicated resources, and sufficient financial requirements. These prerequisites of clinical trials generate a lucrative environment to prefer contract research organization for the execution of clinical studies. Additionally, various companies focus on establishing partnerships with contract research organizations for carrying out clinical studies in an efficient way. For instance, Lipidor has signed an agreement with Cadila Pharmaceuticals to conduct a Phase III trial of the former’s psoriasis drug candidate, AKP-02. Such growing number of collaborations will eventually increase the contribution of contract research organizations in the execution of clinical studies, which will eventually drive the market growth.

The COVID-19 pandemic effect on oncology patients is high in terms of fear, anxiety, and psychological distress. In Europe, many sponsors, collaborator, or CRO, have announced disruptions in their planned and ongoing clinical trials in their SEC filings, press releases, and clinical trial registries and also on social media. There are globally 826 organizations those have reported specific disrupted clinical trials in the public domain of which 8.2% located in the UK, 5% at France, and 3.7% at Switzerland. This is likely to have a negative impact on healthcare contract research organizations (CRO) services market in Europe.

Based on service type, the healthcare contract research organizations (CRO) services market is segmented into early phase development, laboratory services, consulting services, and clinical research services. The early phase development segment is further categorized into discovery studies, chemistry, marketing & manufacturing, and preclinical market. The laboratory services segment is further sub segmented as bio-analytical testing and analytical testing. The clinical research services segment is further divided into phase I, phase II, phase III, and phase IV. In 2019, the clinical research segment accounted for the largest share of the market. Growth of this segment is attributed to the increasing clinical trials and growing R&D investment.

World Health Organization (WHO), National Health Service (NHS), European Federation of Pharmaceutical Industries and Associations (EFPIA), and National Institute for Health Research (NIHR) are among the significant secondary sources associated with the Europe Healthcare contract research organizations (CRO) services market report.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ICON plc
  • IQVIA INC
  • PRA Health Sciences
  • Syneos Health
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Healthcare contract research organizations (CRO) services Market - By Service Type
1.3.2 Europe Healthcare contract research organizations (CRO) services Market - By Therapeutic Indication
1.3.3 Europe Healthcare contract research organizations (CRO) services Market - By End User
1.3.4 Europe Healthcare contract research organizations (CRO) services Market - By Country

2. Europe Healthcare contract research organizations (CRO) services Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research33
3.3 Primary Research

4. Europe Healthcare contract research organizations (CRO) services M.. arket - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Healthcare contract research organizations (CRO) services Market - Europe PEST Analysis
4.3 Expert Opinion

5. Europe Healthcare Contract Research Organizations (CRO) services Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Expenditure in R&D and Outsourcing Activities
5.1.1 Rising Number of Clinical Trials
5.2 Key Market Restraints
5.2.1 Stringent Regulations For Approval Of Drugs
5.3 Key Market Opportunities
5.3.1 Rising Biosimilars and Biologics Market
5.4 Future Trends
5.4.1 Advancement of Technology in Research Field
5.5 Impact Analysis

6. Healthcare Contract Research Organizations (CRO) Services Market - Europe Analysis
6.1 Europe Healthcare Contract Research Organizations (CRO) Services Market Revenue Forecasts and Analysis

7. Europe Healthcare Contract Research Organizations (CRO) Services Market Analysis and Forecasts To 2027 - By Service Type
7.1 Overview
7.2 Europe Healthcare Contract Research Organizations (CRO) Services market, By Service Type 2019 & 2027 (%)
7.2.1 Europe Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027, By Service Type (US$ Mn)
7.2.2 Clinical-Research Services Market Revenue and Forecasts to 2027 (US$ Million)
7.2.3 Early Phase Development Market Revenue and Forecasts to 2027 (US$ Million)
7.2.4 Laboratory Services Market Revenue and Forecasts to 2027 (US$ Million)
7.3 Early Phase Development
7.3.1 Overview
7.3.2 Europe Early Phase Development Market Revenue and Forecast to 2027 (US$ Mn)
7.3.3 Discovery Studies
7.3.3.1 Overview
7.3.3.2 Europe Discovery Studies Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.4 Chemistry, Manufacturing, and Control
7.3.4.1 Overview
7.3.4.2 Europe Chemistry, Manufacturing, and Control Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.5 Pre-Clinical Services
7.3.5.1 Overview
7.3.5.2 Europe Pre-Clinical Services Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Laboratory Services
7.4.1 Overview
7.4.2 Europe Laboratory Services Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.3 Bio-analytical Testing
7.4.3.1 Overview
7.4.3.2 Eur ope Bio-analytical Testing Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.4 Analytical Testing
7.4.4.1 Overview
7.4.4.2 Europe Analytical Testing Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Consulting Services
7.5.1 Overview
7.5.2 Europe Consulting Services Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Clinical Research Services
7.6.1 Overview
7.6.2 Europe Clinical Research Services Market Revenue and Forecasts to 2027 (US$ Mn)
7.6.3 Phase I
7.6.3.1 Overview
7.6.3.2 Europe Phase I Market Revenue and Forecasts to 2027 (US$ Mn)
7.6.4 Phase II
7.6.4.1 Overview
7.6.4.2 Europe Phase II Market Revenue and Forecasts to 2027 (US$ Mn)
7.6.5 Phase III
7.6.5.1 Overview
7.6.5.2 Europe Phase III Market Revenue and Forecasts to 2027 (US$ Mn)
7.6.6 Phase IV
7.6.6.1 Overview
7.6.6.2 Europe Phase IV Market Revenue and Forecasts to 2027 (US$ Mn)

8. Europe Healthcare Contract Research Organizations (CRO) Services Market Analysis - By Therapeutic Application
8.1 Overview
8.2 Europe Healthcare Contract Research Organizations (CRO) Services Market, By Therapeutic Application 2019-2027 (%)
8.2.1 Europe Healthcare Contract Research Organizations (CRO) Services Market Devices Revenue and Forecasts to 2027, By Therapeutic Application (US$ Mn)
8.3 Oncology
8.3.1 Overview
8.3.2 Europe Oncology Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Infectious Diseases
8.4.1 Overview
8.4.2 Europe Infectious Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Cardiovascular Disease
8.5.1 Overview
8.5.2 Europe Cardiovascular Disease Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Respiratory Diseases
8.6.1 Overview
8.6.2 Europe Respiratory Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Neurological Disorders
8.7.1 Overview
8.7.2 Europe Neurological Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Others
8.8.1 Overview
8.8.2 Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

9. Europe Healthcare contract research organizations (CRO) services Market Analysis - By End User
9.1 Overview
9.2 Europe Healthcare contract research organizations (CRO) services Market, By End User 2019-2027 (%)
9.2.1 Europe Healthcare contract research organizations (CRO) services Market Revenue and Forecasts to 2027, By End User (US$ Mn)
9.3 Pharmaceutical and Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Europe Pharmaceutical and Biopharmaceutical Companies Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Medical Device Companies
9.4.1 Overview
9.4.2 Europe Medical Device Companies Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Others (Academic Institutes)
9.5.1 Overview
9.5.2 Europe Others (Academic Institutes) Market Revenue and Forecasts to 2027 (US$ Mn)

10. Healthcare contract research organizations (CRO) services Market Revenue and Forecasts To 2027 - Geographical Analysis
10.1 Europe Healthcare contract research organizations (CRO) services Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 Europe: Healthcare Contract Research Organizations (CRO) Services Market-Revenue and Forecasts to 2027 (US$ Million)
10.1.3 Europe Healthcare Contract Research Organizations (CRO) Services Market, by Service Type - Revenue and Forecast to 2027 (USD Million)
10.1.3.1 Europe Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services - Revenue and Forecast to 2027 (USD Million)
10.1.3.2 Europe Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development - Revenue and Forecast to 2027 (USD Million)
10.1.3.3 Europe Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services - Revenue and Forecast to 2027 (USD Million)
10.1.4 Europe Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Indication - Revenue and Forecast to 2027 (USD Million)
10.1.5 Europe Healthcare Contract Research Organizations (CRO) Services Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.1.6 Europe: Healthcare Contract Research Organizations (CRO) Services Market, by Country, 2019 & 2027 (%)
10.1.7 Germany Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.7.1 Germany Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8 Germany Healthcare Contract Research Organizations (CRO) Services Market, by Service Type - Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Germany Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services - Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Germany Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development - Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Germany Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services - Revenue and Forecast to 2027 (USD Million)
10.1.9 Germany Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Indication - Revenue and Forecast to 2027 (USD Million)
10.1.10 Germany Healthcare Contract Research Organizations (CRO) Services Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.1.11 UK Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.11.1 UK Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.12 UK Healthcare Contract Research Organizations (CRO) Services Market, by Service Type - Revenue and Forecast to 2027 (USD Million)
10.1.12.1 UK Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services - Revenue and Forecast to 2027 (USD Million)
10.1.12.2 UK Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development - Revenue and Forecast to 2027 (USD Million)
10.1.12.3 UK Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services - Revenue and Forecast to 2027 (USD Million)
10.1.13 UK Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Indication - Revenue and Forecast to 2027 (USD Million)
10.1.14 UK Healthcare Contract Research Organizations (CRO) Services Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.1.15 France Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.15.1 France Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.16 France Healthcare Contract Research Organizations (CRO) Services Market, by Service Type - Revenue and Forecast to 2027 (USD Million)
10.1.16.1 France Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services - Revenue and Forecast to 2027 (USD Million)
10.1.16.2 France Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development - Revenue and Forecast to 2027 (USD Million)
10.1.16.3 France Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services - Revenue and Forecast to 2027 (USD Million)
10.1.17 France Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Indication - Revenue and Forecast to 2027 (USD Million)
10.1.18 France Healthcare Contract Research Organizations (CRO) Services Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.1.19 Italy Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.19.1 Italy Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.20 Italy Healthcare Contract Research Organizations (CRO) Services Market, by Service Type - Revenue and Forecast to 2027 (USD Million)
10.1.20.1 Italy Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services - Revenue and Forecast to 2027 (USD Million)
10.1.20.2 Italy Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development - Revenue and Forecast to 2027 (USD Million)
10.1.20.3 Italy Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services - Revenue and Forecast to 2027 (USD Million)
10.1.21 Italy Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Indication - Revenue and Forecast to 2027 (USD Million)
10.1.22 Italy Healthcare Contract Research Organizations (CRO) Services Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.1.23 Spain Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.23.1 Spain Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.24 Spain Healthcare Contract Research Organizations (CRO) Services Market, by Service Type - Revenue and Forecast to 2027 (USD Million)
10.1.24.1 Spain Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services - Revenue and Forecast to 2027 (USD Million)
10.1.24.2 Spain Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development - Revenue and Forecast to 2027 (USD Million)
10.1.24.3 Spain Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services - Revenue and Forecast to 2027 (USD Million)
10.1.25 Spain Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Indication - Revenue and Forecast to 2027 (USD Million)
10.1.26 Spain Healthcare Contract Research Organizations (CRO) Services Market, by End User - Revenue and Forecast to 2027 (USD Million)

11. Impact of COVID-19 Pandemic on Europe Healthcare contract research organizations (CRO) services Market
11.1 Europe: Impact Assessment of COVID-19 Pandemic

12. Company Profiles
12.1 ICON plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 IQVIA INC.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Laboratory Corporation of America Holdings (Covance)
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 PRA Health Sciences
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Syneos Health
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms
Note: Product cover images may vary from those shown
  • ICON plc
  • IQVIA INC
  • Laboratory Corporation of America Holdings (Covance)
  • PRA Health Sciences
  • Syneos Health
Note: Product cover images may vary from those shown
Adroll
adroll